id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-P-0474-0007,FDA,FDA-2004-P-0474,Withdrawal of Approval of 128 Suitability Petitions,Notice,N-Notice,2011-04-07T04:00:00Z,2011,4,2011-04-07T04:00:00Z,,2011-04-07T18:36:25Z,,0,0,090000648075ccd4
FDA-2004-P-0474-0006,FDA,FDA-2004-P-0474,Withdrawal of Approval of 128 Suitability Petitions; Correction,Notice,NCR-Notice of Correction,2008-10-07T04:00:00Z,2008,10,2008-10-07T04:00:00Z,,2008-10-07T13:03:07Z,E8-23721,0,0,090000648073b55d
FDA-2004-P-0474-0005,FDA,FDA-2004-P-0474,FDA/CDER to King & Spalding LLP,Other,PAV-Petition Approval,2007-04-02T04:00:00Z,2007,4,,,2008-04-12T00:50:25Z,,0,0,0900006480475ce4
FDA-2004-P-0474-0004,FDA,FDA-2004-P-0474,FDA,Notice,Withdrawal,2007-02-27T05:00:00Z,2007,2,,,2017-09-27T18:35:12Z,E7-3043,0,0,0900006480475ce3
FDA-2004-P-0474-0003,FDA,FDA-2004-P-0474,FDA/CDER to King & Spalding LLP,Other,LET-Letter,2004-12-13T05:00:00Z,2004,12,,,2008-04-12T00:50:25Z,,0,0,0900006480475ce2
FDA-2004-P-0474-0002,FDA,FDA-2004-P-0474,FDA/ DDM to King & Spalding LLP,Other,ACK-Acknowledgement Letter,2004-06-10T04:00:00Z,2004,6,,,2008-04-12T00:50:25Z,,0,0,0900006480475ce1
FDA-2004-P-0474-0001,FDA,FDA-2004-P-0474,FDA/ DDM to King & Spalding LLP,Other,ACK-Acknowledgement Letter,2004-06-10T04:00:00Z,2004,6,,,2008-04-12T00:50:25Z,,0,0,0900006480475cd7